PhilipEliadesMD, FAAD

PubMed

• 2 citations
  Litigation Arising From Minimally Invasive Cosmetic Procedures: A Review of the Literature.
  Brian P. Hibler, Philip J Eliades, Karen C. Kagha, Mathew M. Avram> ;Dermatologic Surgery. 2021 Aug 18
• 9 citations
  Use of Etanercept in a Series of Pediatric Patients With Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis Spectrum Disease
  Philip Eliades, Maira Fonseca, Joanna Harp> ;JAMA Dermatology. 2020 Aug 1
• 3 citations
  New Insights into the Molecular Distinction of Dysplastic Nevi and Common Melanocytic Nevi-Highlighting the Keratinocyte-Melanocyte Relationship.
  Philip Eliades, Hensin Tsao> ;The Journal of Investigative Dermatology. 2016 Oct 1
• 110 citations
  Genetics of Melanocytic Nevi
  Mi Ryung Roh, Philip Eliades, Sameer Gupta, Hensin Tsao> ;Pigment Cell & Melanoma Research. 2015 Nov 1
• 43 citations
  High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma.
  Philip Eliades, Brian J. Abraham, Zhenyu Ji, David Miller, Camilla L. Christensen, Nicholas Kwiatkowski, Raj Kumar, Ching-Ni Njauw, Michael Taylor, Benchun Miao, Tingh...> ;The Journal of Investigative Dermatology. 2018 Jul 1
• 9 citations
  Cutaneous melanoma in women.
  Mi Ryung Roh, Philip Eliades, Sameer Gupta, Jane M Grant-Kels, Hensin Tsao> ;International Journal of Women's Dermatology. 2017 Mar 1
• 113 citations
  Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome
  Efthymia Soura, Philip Eliades, Kristen M. Shannon, Alexander J. Stratigos, Hensin Tsao> ;Journal of the American Academy of Dermatology. 2016 Mar 1
• 47 citations
  Hereditary melanoma: Update on syndromes and management: Emerging melanoma cancer complexes and genetic counseling.
  Efthymia Soura, Philip Eliades, Kristen M. Shannon, Alexander J. Stratigos, Hensin Tsao> ;Journal of the American Academy of Dermatology. 2016 Mar 1
• 6 citations
  A novel multi-CDK inhibitor P1446A-05 restricts melanoma growth and produces synergistic effects in combination with MAPK pathway inhibitors
  Philip Eliades, David Miller, Benchun Miao, Raj Kumar, Michael Taylor, Shama Buch, Sreesha P Srinivasa, Keith T. Flaherty, Hensin Tsao> ;Cancer Biology & Therapy. 2016 Jan 25
• 3 citations
  Oncogene-directed small molecule inhibitors for the treatment of cutaneous melanoma.
  Philip Eliades, Keith T. Flaherty, Hensin Tsao> ;Melanoma Management. 2015 May 18
• 11 citations
  Cutaneous Melanoma in Women.
  Mi Ryung Roh, Philip Eliades, Sameer Gupta, Hensin Tsao> ;International Journal of Women's Dermatology. 2015 Feb 1
• 10 citations
  Unilateral Pedicle Screw Fixation is Associated with Reduced Cost and Similar Outcomes in Selected Patients Undergoing Minimally Invasive Transforaminal Lumbar Interbo...
  Philip Eliades, Jason P. Rahal, Daniel B. Herrick, Brian M. Corliss, Ron I. Riesenburger, Steven W. Hwang, James Kryzanski> ;Cureus. 2015 Feb 10
• 82 citations
  Anti-CD45RB/anti-TIM-1-induced tolerance requires regulatory B cells.
  Kang Mi Lee, James I. Kim, R. Stott, J. Soohoo, Matthew R O’Connor, Heidi Yeh, Gaoping Zhao, Philip Eliades, Courtney Fox, Nan Cheng, Shaoping Deng, James F. Markmann> ;American Journal of Transplantation. 2012 Aug 1
• 5 citations
  Generation of adaptive regulatory T cells by alloantigen is required for some but not all transplant tolerance protocols.
  James I. Kim, Matthew R O’Connor, Patrick E. Duff, Gaoping Zhao, Kang Mi Lee, Philip Eliades, Shaoping Deng, Heidi Yeh, Andrew J. Caton, James F. Markmann> ;Transplantation. 2011 Apr 15
• Join now to see all

Journal Articles

• Oncogene-directed small molecule inhibitors for the treatment of cutaneous melanoma  
  Eliades P, Flaherty K, Tsao H, Melanoma Management, 5/2015